je.st
news
Ariad receives nod to resume US sales of leukemia drug
2013-12-21 12:09:24| Biotech - Topix.net
Seven weeks after Ariad Pharmaceuticals Inc. was forced to halt US sales of its leukemia drug, prompting an outcry from patients and doctors, the Food and Drug Administration issued new safety measures Friday that will allow the Cambridge biotech to resume selling the medicine.
Tags: sales
drug
resume
receives
Category:Biotechnology and Pharmaceuticals